期刊文献+

2型糖尿病家系糖耐量正常的一级亲属脂代谢的紊乱 被引量:1

Dyslipidemia of Normoglycemic First-Degree Relatives of Type 2 Diabetes Mellitus
下载PDF
导出
摘要 2型糖尿病(T2DM)家系中糖耐量正常的一级亲属在发生糖代谢异常前,往往已存在脂代谢紊乱;而其与胰岛素抵抗、脂代谢中关键酶的活性改变、脂联素水平下降以及家系中某些遗传易感性相关;并可加速T2DM的发生和发展,同时增加心血管疾病的发生率。因此及早筛查这些脂代谢异常者并给予积极干预和治疗具有重要的临床意义。 The normoglycemic first-degree relatives of type 2 diabetes mellitus(T2DM) are already associated with dyslipidemia before glucose intolerance. The insulin resistance, the change of key enzyme in the lipid mebabolism, the decrease of adiponectin and the genetic predisposition are associated with the dyslipidemia. The dyslipidemia accelerates the progress of T2DM and increases the incidence rate of cardiovascular diseases. In this way, the screening of the dyslipidemic relatives and the intervention and treatment will postpone the development of T2DM and reduce the incidence rate of cardiovascular diseases.
作者 张小英 刘伟
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第9期1002-1005,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海交通大学医学院自然科学基金(02XJ21016)资助项目
关键词 2型糖尿病 一级亲属 胰岛素抵抗 脂蛋白脂酶 脂联素 遗传易感性 type 2 diabetes mellitus first-degree relatives insulin resistance lipoprotein lipaseadiponectin genetic predisposition
  • 相关文献

参考文献3

二级参考文献15

  • 1Cabrero A, Alegret M, Sanchez RM, et al. Bezafibrate reduces mRNA Levels of adipoeyte markers and increases fatty acid oxidation in primary culture of adipoeytes. Diabetes, 2001, 50:1883-1889.
  • 2Flavell DM, Pineda JI, Jamshidi Y, et al. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in type Ⅱ diabetic subjects. Diabetologia,2000, 43: 673-680.
  • 3Vohl MC, lepage P, Gandet D, et al. Molecular scanning of the humem PPARα gene., association of the L162V mutation with hyperpobetalipoproteinmia. J Lip Res, 2000, 41: 945-952.
  • 4Djonadi F, Weinheimer CJ, Saffitz JE, et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activator receptor alpha-deficient mice. J Clin Invest, 1998, 102: 1083-1091.
  • 5Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome prollferator-activator (PPARs): tissue distribution of PPAR-alpha/-beta and gamma in the adult rat. Endocrinology, 1996,137 (2): 354-366.
  • 6Zhou YT, Wang ZW, Higa M, et al. Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA, 1999, 96(5): 2391-2395.
  • 7Flavell DM, Jorra IP, Jamshldi Y, et al. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in type Ⅱ diabetic subjects. Diabetologia, 2000, 43(5): 673-680.
  • 8Djonadi F, Weinheimer CJ, Saffitz JE, et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-actirator receptor alpha-deficient mice. J Clin Invest,1998, 102(6): 1083-1091.
  • 9Lacquemant C, Lepretre F, Pineda TI, et al. Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab, 2000, 26(5): 393-401.
  • 10Kaplan F, Al-Majali K, Betteridge DJ. PPARs, insulin resistance and type 2 diabetes, j Cardiovase Risk, 2001, 8(4): 211-217.

共引文献16

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部